Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 223.50
+3.68 (1.67%)
Jul 31, 2026, 3:29 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 19.45 billion as of July 31, 2026. Its market cap has increased by 155.44% in one year.
Market Cap
19.45B
Enterprise Value
15.23B
Revenue
6.41B
Ranking
n/a
PE Ratio
46.34
Stock Price
223.50
ChartMarket Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 19.45B, an increase of 17,338.90%. That is a compound annual growth rate of 20.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 19.45B | 170.32% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 55.48B |
| Orchid Pharma | 50.73B |
| RPG Life Sciences | 45.95B |
| Solara Active Pharma Sciences | 24.47B |
| Beta Drugs | 22.24B |
| Indoco Remedies | 20.00B |
| Sakar Healthcare | 19.70B |
| Windlas Biotech | 17.70B |